Tradestie Institutional Equity Comparison Engine
SYK vs PHG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SYK Overall Edge
SYK Captures Institutional Edge (2โ2 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Stryker Corporation (SYK) driven by superior Growth & Margin, Options & Structure while PHG counters with relative strength in Valuation, Momentum & Technical. Fundamentally, SYK trades at 19.0x Forward P/E with 24.0% operating margin (+7.6% YoY revenue) versus PHG at 14.9x Forward P/E and 8.8% operating margin (+2.1% YoY). In options structure, SYK sits in SURGE (5th %ile IV; Dealer Gamma Walls on Pro) against PHG sits in SURGE (2nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
PHG
SYK 19.0x vs PHG 14.9x Fwd P/E
Growth & Margin Winner
SYK
Op Margin 24.0% vs 8.8% ยท YoY +7.6% vs +2.1%
Momentum & Technical Winner
PHG
1Y -16.8% vs +4.5% ยท 52W Pos 36% vs 67%
Options & Structure Winner
SYK
SURGE (5th %ile IV) vs SURGE (2nd %ile IV)
SYK
NYSE
Stryker Corporation
Surgical & Medical Instruments & Apparatus
$310.79
+0.37% 1D
Market Cap
$118.9B
1M Return
+5.47%
1Y Return
-16.77%
Forward P/E
19.0x
Unified AI Score
46.5 / 100
HOLD
Tech 37.0
Fund 49.0
Flow 58.0
Mom 60.0
PHG
NYSE
Koninklijke Philips N.V.
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$30.21
-0.43% 1D
Market Cap
$29.6B
1M Return
+17.37%
1Y Return
+4.46%
Forward P/E
14.9x
Unified AI Score
28.4 / 100
SELL
Tech 50.0
Fund 23.0
Flow 54.0
Mom 11.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SYK -16.77%
PHG +4.46%
Spread: +21.23 pp (PHG Lead)
Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)
| Period | SYK Revenue | PHG Revenue | SYK Op. Margin | PHG Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| Q3 '25 | $24.2B | $8.44B | 19.9% | 7.7% | SYK |
| Q4 '25 | $28.7B | $10.0B | 25.3% | 11.1% | SYK |
| Q1 '26 | $24.1B | $7.66B | 15.5% | 6.2% | SYK |
| Q2 '26 | $26.4B | $8.55B | 25.2% | 14.0% | SYK |
| Q3 '26 | $26.1B | $8.62B | 20.4% | 3.8% | SYK |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SYK | PHG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $118.9B | $29.6B | Larger Scale | SYK |
| Trailing P/E Ratio Valuation | 33.3x | 63.2x | Lower Multiple | SYK |
| Forward P/E Ratio Valuation | 19.0x | 14.9x | Lower Multiple | PHG |
| Revenue Growth (YoY) Growth | +7.6% | +2.1% | Higher Growth | SYK |
| Operating Margin (TTM) Profitability | 24.0% | 8.8% | Higher Margin | SYK |
| Net Profit Margin Profitability | 13.8% | 5.4% | Higher Margin | SYK |
| Return on Equity (ROE) Capital Efficiency | 16.0% | 8.6% | Higher ROE | SYK |
| 52-Week Range Position Momentum | 36% ($267โ$389) | 67% ($24โ$33) | Stronger Trend | PHG |
| Beta / 30D Volatility Risk Regime | 0.22ฮฒ ยท 50% Vol | 0.73ฮฒ ยท 38% Vol | Lower Realized Risk | PHG |
| Unified Institutional Score Composite Signal | 46.5 / 100 (HOLD) | 28.4 / 100 (SELL) | Higher Composite | SYK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SYK vs PHG Buy Guide
SYK
SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
PHG
SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
2nd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SYK nor PHG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.